It's the (semi) new paradigm.
Buy INJ.
You're welcome.
Injective looks promising. Frankly there's so many promising projects out there its hard to keep up.
INJ and SXP have long been in consolidating phase, great for stacking SATS when they (finally) break out. But there is another that will turn the entire space upside down...
